Summit Therapeutics Inc. (SMMT) stock
SMMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$10.67−1.15 (-9.73%)
Close on Nov 17, 2026Market cap $8.51BP/E –Yield –
Summit Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Summit Therapeutics's operating margin for the twelve months ending Jun 30, 2023 was -268266.8%. For fiscal 2022 it was -10225.4%, against -4764.3% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -10225.4% | −5461.1 |
| FY2021 | Dec 31, 2021 | -4764.3% | −4773.7 |
| FY2019 | Jan 31, 2019 | 9.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -7700.0% | −6211.4 |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -5400.9% | +36230.7 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -8863.2% | −49.1 |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -10377.3% | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -1488.6% | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -41631.6% | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -8814.1% | – |
See a number that looks wrong?